Hereditary sensory and autonomic neuropathy type 4

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:642OMIM:256800G60.8
Who is this for?
Show terms as
12Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary sensory and autonomic neuropathy type 4 (HSAN4), also known as congenital insensitivity to pain with anhidrosis (CIPA), is a rare autosomal recessive disorder caused by mutations in the NTRK1 gene (also called TRKA), which encodes the neurotrophic tyrosine kinase receptor type 1. This receptor is essential for the development and survival of sympathetic postganglionic neurons and nociceptive sensory neurons. The condition is characterized by the absence of pain sensation (insensitivity to pain), inability to sweat (anhidrosis), and intellectual disability of variable severity. Because the autonomic nervous system is affected, patients cannot regulate body temperature through sweating, leading to recurrent episodes of unexplained high fevers (hyperthermia), which can be life-threatening, particularly in infancy and early childhood. The insensitivity to pain results in repeated injuries, fractures, burns, and self-mutilating behaviors such as biting of the tongue, lips, and fingers. Patients frequently develop skin ulcers, joint deformities (Charcot joints), and osteomyelitis due to unrecognized trauma and infections. Corneal scarring from unnoticed eye injuries may also occur. The peripheral nervous system is primarily affected, with loss of small myelinated and unmyelinated nerve fibers. Thick skin and hyperkeratosis of the palms and soles are common findings. There is currently no cure or disease-modifying treatment for HSAN4. Management is supportive and multidisciplinary, focusing on prevention and early treatment of injuries, infections, and overheating. Temperature regulation through environmental control is critical. Dental care is important to prevent self-inflicted oral injuries. Orthopedic monitoring is necessary to manage fractures and joint complications. Families and caregivers must be educated about the risks associated with the inability to perceive pain and the importance of vigilant supervision, especially during childhood.

Also known as:

Clinical phenotype terms— hover any for plain English:

Self-mutilationHP:0000742AnhidrosisHP:0000970Recurrent Staphylococcus aureus infectionsHP:0002726Abnormality of peripheral nerve conductionHP:0003134Pain insensitivityHP:0007021Impaired temperature sensationHP:0010829Aplasia of the sweat glandsHP:0011136Painless fractures due to injuryHP:0002661Neuropathic arthropathyHP:0002821Trophic limb changesHP:0003091Abnormality of humoral immunityHP:0005368Premature loss of teethHP:0006480Nail-bitingHP:0012170AbscessHP:0025615
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary sensory and autonomic neuropathy type 4.

View clinical trials →

No actively recruiting trials found for Hereditary sensory and autonomic neuropathy type 4 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary sensory and autonomic neuropathy type 4 community →

Specialists

12 foundView all specialists →
JR
Julie Richer
YORKVILLE, IL
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
CC
Cheng-Chun Chiang
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
YW
Yu-Che Wu
SAN DIEGO, CA
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
CL
Chiao-Hsin Lan
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
KW
Kuan-Chieh Wang
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
HT
Hsuan-Ching Tang
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
SC
Shin-Tsu Chang
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
AK
Anders Kjellberg
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
RG
Rebecca Gustafsson
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
PA
Pavel Antonsson
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
HH
Henrik Hedelin
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication
AM
Amytice Mirchi
PHILADELPHIA, PA
Specialist
1 Hereditary sensory and autonomic neuropathy type 4 publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary sensory and autonomic neuropathy type 4.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary sensory and autonomic neuropathy type 4Forum →

No community posts yet. Be the first to share your experience with Hereditary sensory and autonomic neuropathy type 4.

Start the conversation →

Latest news about Hereditary sensory and autonomic neuropathy type 4

No recent news articles for Hereditary sensory and autonomic neuropathy type 4.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary sensory and autonomic neuropathy type 4

What is Hereditary sensory and autonomic neuropathy type 4?

Hereditary sensory and autonomic neuropathy type 4 (HSAN4), also known as congenital insensitivity to pain with anhidrosis (CIPA), is a rare autosomal recessive disorder caused by mutations in the NTRK1 gene (also called TRKA), which encodes the neurotrophic tyrosine kinase receptor type 1. This receptor is essential for the development and survival of sympathetic postganglionic neurons and nociceptive sensory neurons. The condition is characterized by the absence of pain sensation (insensitivity to pain), inability to sweat (anhidrosis), and intellectual disability of variable severity. Becau

How is Hereditary sensory and autonomic neuropathy type 4 inherited?

Hereditary sensory and autonomic neuropathy type 4 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary sensory and autonomic neuropathy type 4 typically begin?

Typical onset of Hereditary sensory and autonomic neuropathy type 4 is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Hereditary sensory and autonomic neuropathy type 4?

12 specialists and care centers treating Hereditary sensory and autonomic neuropathy type 4 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.